Cite
HARVARD Citation
Kulkarni, R. et al. (2017). Week 48 resistance analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF versus Atazanavir + Ritonavir + Emtricitabine/Tenofovir DF in HIV-1 infected women (WAVES study GS-US-236-0128). HIV clinical trials. 18 (4), pp. 164-173. [Online].